RSS feed

Publications by Bente Magny Bergersen

14 publications found

Original articles

Leiva RA, Bergersen BM, Finbråten AK, Sandvei PK, Simonsen Ø, Rosseland CM, Hagen K, Young L, Roberts RS, Mikkelsen Y, Singh R, Lagging M, Dalgard O (2022)
High real-world effectiveness of 12-week elbasvir/grazoprevir without resistance testing in the treatment of patients with HCV genotype 1a infection in Norway
Scand J Gastroenterol, 58 (3), 264-268
DOI 10.1080/00365521.2022.2118555, PubMed 36063075

Whittaker R, Nilsen Ø, Myrberg AJ, Angeltvedt RM, Bergersen BM, Kløvstad H (2020)
Norway is on the verge of ending the HIV epidemic
Tidsskr Nor Laegeforen, 140 (18)
DOI 10.4045/tidsskr.20.0748, PubMed 33322887

Brandsaeter BJ, Pillgram M, Berild D, Kjekshus H, Kran AM, Bergersen BM (2011)
Hospitalised patients with suspected 2009 H1N1 influenza A in a hospital in Norway, July - December 2009
BMC Infect Dis, 11, 75
DOI 10.1186/1471-2334-11-75, PubMed 21435254

Skeie L, Bugge H, Negaard A, Bergersen BM (2009)
Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study
HIV Med, 11 (3), 170-7
DOI 10.1111/j.1468-1293.2009.00761.x, PubMed 19780861

Bergersen BM, Schumacher A, Sandvik L, Bruun JN, Birkeland K (2006)
Important differences in components of the metabolic syndrome between HIV-patients with and without highly active antiretroviral therapy and healthy controls
Scand J Infect Dis, 38 (8), 682-9
DOI 10.1080/00365540500361302, PubMed 16857615

Bergersen BM, Sandvik L, Ellingsen I, Bruun JN (2005)
Lipoatrophic men 44 months after the diagnosis of lipoatrophy are less lipoatrophic but more hypertensive
HIV Med, 6 (4), 260-7
DOI 10.1111/j.1468-1293.2005.00305.x, PubMed 16011531

Bergersen BM, Tonstad S, Sandvik L, Bruun JN (2005)
Low prevalence of high-density lipoprotein cholesterol level < 1 mmol/L in non-nucleoside reverse transcriptase inhibitor recipients
Int J STD AIDS, 16 (5), 365-9
DOI 10.1258/0956462053888808, PubMed 15949067

Bergersen BM, Sandvik L, Bruun JN, Tonstad S (2004)
Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects
Eur J Clin Microbiol Infect Dis, 23 (8), 625-30
DOI 10.1007/s10096-004-1177-6, PubMed 15322938

Bergersen BM, Sandvik L, Bruun JN (2004)
Body composition changes in 308 Norwegian HIV-positive patients
Scand J Infect Dis, 36 (3), 186-91
DOI 10.1080/00365540410019273, PubMed 15119363

Bergersen BM, Sandvik L, Dunlop O, Birkeland K, Bruun JN (2003)
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naïve and HIV-negative controls: results from a Norwegian study of 721 patients
Eur J Clin Microbiol Infect Dis, 22 (12), 731-6
DOI 10.1007/s10096-003-1034-z, PubMed 14610658

Review articles

Bergersen BM (2006)
Cardiovascular risk in patients with HIV Infection: impact of antiretroviral therapy
Drugs, 66 (15), 1971-87
DOI 10.2165/00003495-200666150-00006, PubMed 17100407

Other articles

Whittaker R, Nilsen O, Myrberg AJ, Angeltvedt RM, Bergersen BM, Klovstad H (2020)
Norway is in the process of stopping the HIV epidemic
Tidsskr. Nor. Laegeforen., 140 (18), 1864-1866

Book chapters

Sandvik L, Dunlop O, Birkeland KI, Bruun JN, Bergersen BM (2003)
Prevalence of hypertension in HIV-positive patients on highly active retroviral therapy (HAART) compared with HAART-naive and HIV-negative controls: results from a Norwegian study of 721 patients
In European journal of clinical microbiology & infectious diseases, Vieweg, Wiesbaden, 22(2003)12, s.731-6
BIBSYS 041705173

Theses

Bergersen BM (2005)
The lipodystrophy syndrome in HIV-positive patients: body composition changes and cardiovascular risk factors
Department of Infectious Diseases, Ullevål University Hospital Faculty of Medicine, University of Oslo, Oslo, 1 b. (flere pag.)
BIBSYS 051513463, ISBN 82-8080-144-8